Stress hyperglycemia ratio as a prognostic indicator for long-term adverse outcomes in heart failure with preserved ejection fraction.

Authors:
Mohammed AQ; Luo Y; Wang K; Su Y; Liu L and 8 more

Journal:
Cardiovasc Diabetol

Publication Year: 2024

DOI:
10.1186/s12933-024-02157-7

PMCID:
PMC10865536

PMID:
38350936

Journal Information

Full Title: Cardiovasc Diabetol

Abbreviation: Cardiovasc Diabetol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Vascular Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateOur study adhered to the principles of the Helsinki Declaration and received approval from the ethical review board of Shanghai Tenth People’s Hospital. All participating individuals in this research provided written informed consent. Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding This work was supported in part by Chinese National Natural Science Foundation (82170521), Shanghai Natural Science Foundation of China (21ZR1449500), Foundation of Shanghai Municipal Health Commission (202140263), Tibet Natural Science Foundation of China (XZ2022ZR-ZY27(Z), XZ202301ZR0032G), Foundation of Chongming (CKY2021-21, CKY2020-29), Clinical Research Plan of Shanghai Tenth People’s Hospital (YNCR2A001), and Clinical Research Plan of SHDC (SHDC2020CR4065)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025